1,0
4. März 2026
Aktueller Mitarbeiter, mehr als 10 Jahre
New York, NY
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
None. The c suite of this company has a horrendous track record. Last week the ceo approval rate was 21% and 1.9 rating. Suddenly ballot stuffing that is done at their prior companies?
Kontras
Everything. Look at the history of reviews. Then suddenly marketing speak reviews with a jump from 21% and 1.9 that is shady. Look at the track record, the c suite who had a 400 million equity investment walk? Ex olive and change healthcare execs?